RSS
 

OpusPoint Partners: Trendsetters in the Life Science and Healthcare Industry

09 Sep

OpusPoint Partners are now the trendsetters in the advancement of life science and healthcare. They are on a quest to revolutionize the way in which the newest innovations in healthcare will be delivered to the market. Their vision requires that time and money be invested into companies whose innovations require that extra financial push to make it into the industry.

OpusPoint Partners was founded by visionaries Michael S. Weiss and Dr. Lindsay Rosenwald in 2009 with dreams of improving the levels of healthcare and medicine throughout the world. This was only one of a number of biotech companies founded by these two men who have retained their passion for the world of biotechnology with their combined 40 years worth of experience, investing in the fields of life sciences and biotechnology and ensuring that the future of all mankind is stronger and healthier.

Dr. Lindsay Rosenwald is also accredited with the founding of another company called Cougar Biotechnology Inc. which is Los Angeles based and has an excellent portfolio which includes experimental drugs for cancer which have been impressing researchers and investors worldwide. One of these drugs has received a wealth of attention because of its success in the treatment of prostate cancer that has advanced to the late stages. On July 10, 2009, Johnson and Johnson purchased Cougar Biotech Labs for an estimated one billion dollars.

OpusPoint Partners with Lindsay Rosenwald has been focusing on growing the connections with the investment and biotechnology communities and building these strong business links. Integrity is the hallmark of their operation and this trait is practiced with full and open disclosure and honesty in their investing. They found that when good core values are shared in the establishment of the business the companies and industry leaders develop strong business relationships. Recognition that integrity is not only a good business practice but is intrinsically interwoven into the fabric of the organization’s culture keeps all of the parties grounded and focused.

These business teams are made up of various individuals and corporations as well as investors and researchers with a common mission to help the emerging companies attain their critical business goals and succeeding in providing the world with revolutionary innovations to improve the diagnosis and treatment of many diseases. Collectively with these teams, OpusPoint Partners will continue to make new discoveries in these fields and invest more into research companies that are on the threshold of accomplishing great medical breakthroughs.

Dr. Lindsay Rosenwald and OpusPoint Partners have taken the area of biotech investing to new heights. They are setting the trend by raising the bar for investing and advising biotechnical facilities, by employing a strong set of values and insisting that sound business principles be applied. With these business tools being utilized they believe that investors can be provided with optimal returns, without increased exposure to the risks. This formula has been tested and has proven to be effective.

Dr. Rosenwald is well prepared for the challenges ahead as he has had more than seventeen years experience as a biotechnology entrepreneur on Wall Street. He has kept active in the founding and re-capitalization of private and public companies that are focused on the life sciences and biotech industries. Dr. Rosenwald has both an M.D. form the Temple University School of Medicine as well as a B.S. in Finance from Pennsylvania State University.

For thirteen years from 1994 to 2007 Dr. Rosenwald managed billions of dollars for the Aries Funds which placed more than one billion dollars on healthcare investments and peaked with its assets under his management. He also managed the Orion Fund from 2002 to 2006. The Orion Fund is dedicated to the allocation of private biotechnology investing in particular in PIPEs.

OpusPoint Partners retains its founding principle which is to establish a strong and successful conglomeration that remains committed to honesty and integrity in the areas of life science and healthcare. Business leaders in today’s competitive business environments are pursued by temptations to take the short cuts and compromise their ethics in an effort to produce positive clinical trials to have an impact on their earnings and profits.

OpusPoint Partners has a completely different philosophy. It remains firmly committed to its shareholders made up of investors and employees while still reinforcing fair play in all of its dealings especially when it comes to the testing, investigation and manufacture of drugs.

Change can sometimes be difficult and it will take some work to alter the age-old procedures and techniques in medicine while still remaining within ethical boundaries. Time, money and dedication must be pumped into the projects to avoid the need by the companies to ignore ethics and cross the line of what is right, just to increase the profits.

The future of OpusPoint Partners is promising because of the experienced leadership of Michael Weiss and Dr. Lindsay Rosenwald. As a dual team it is expected that their expertise will be instrumental in the trendsetting modus operandi that improves the areas of medical treatments as well as the diagnosis and treatment of patients.

The successes of OpusPoint are already visible. The company within the last few years has been performing above the initial projected goals and have financed over twenty companies in less than a two year period, proving that the application of best practices and fine-tuned processes have produced promising results and returns in the worlds of finance and drug research.

Dr. Lindsay Rosenwald is on the Board of Directors for the Republican Jewish Coalition which affords him the opportunity to forge close connections to industry leaders in the biotechnology financial sector. OpusPoint Partners are eagerly anticipating a future that is marked by even more successes under its leadership.

 
Comments Off

Posted in Lindsay Biotechnology

 

A Step Ahead By Lindsay Rosenwald In Field Of HealthCare & LifeScience Investment

08 Jun

OpusPoint Partners:
Investing in the Future ofHealthcare and Life Sciences

At OpusPoint Partners,we have a vision for an amazing future for the life science and healthcare industry. We believe in that vision so strongly that we are investingmoney and time to advance life sciences and biotechnology. We also believe in a strong, healthy future for human kind. With proper funding and research, we know that the quality of healthcare can be catapulted to a new and more effective level.

A Vision for the Future of Healthcare
With this vision in mind, Michael S. Weiss and Dr. LindsayRosenwald created OpusPoint Partners in 2009. These men have over 40 years of combined experience in the fields of healthcare, life sciences and biotechnology investing. Both are creative thinkers who have founded a number of biotech companies over the years.

Dr. Lindsay A. Rosenwaldhas most recently founded Cougar Biotechnology Inc.,which is a Los Angeles-based firm that focuses on the field of oncology. Cougar’s oncology portfolio includes some promising experimental drugs effective in treatingnumerousforms of cancer. One of those in particular has drawn the interests of researchers and investors. It has proven to work well at treating late-stage prostate cancer. Dr. Lindsay Rosenwald negotiated a deal with Johnson & Johnson for Cougar Biotech Labs at a price of approximately one billion dollars in July of 2009.

Achieving the Objectives
The objective of Lindsay Rosenwald and OpusPoint Partners is twofold: to move forward withintegrity in achieving long-term goals and short-termgains, and to build solid relationships in both the world of investing and biotechnology. By establishing strong relationships withother industry leaders who share similar values, they believe that these goals and objectives can be obtained without the sacrifice of their principles and standards.

For OpusPoint Partners, honest investing with full and open disclosure is more than just good business. This is a way of life.They currently work with a wide range of corporations to create a team approach to supporting emerging new businesses in an effort to reach critical goals. Dr. Lindsay Rosenwald and OpusPoint Partners have made a genuine commitment to discover and invest in innovative technologies in the fields of life sciences and healthcare.These pioneers of research and investment believe in a better future for us all; a future where diseases are diagnosed and treated by more effective methods.
At OpusPoint Partners, Dr. Lindsay Rosenwald, his business partners and colleagues, believe in a world where people’s lives and health are greatly improved. They believe in creating a future where mankind achieves a much stronger quality of life. Through thisunique vision they are making a true difference in theirworld. In order to attain this dream of a better tomorrow for us all, their journey often involves providing advisory services to start-up businesses. Sometimes it requires investing in publicly-traded companies.
Raising the Bar
Dr. Lindsay Rosenwald and OpusPoint Partners, is working to raise the bar for investors. Their efforts include advising emerging biotechnical research facilities. They believe that a strong moral compass along with sound business principles can significantly minimize risks and thereby maximize returns for investors and so far, this unique formula is proving to be successful.
For the past 17 years, Dr. Rosenwald has been a well-respected Wall Street biotechnology entrepreneur. His business ethics have not gone unnoticed. He has, in fact, been instrumental in the founding and re-capitalization of dozens of private and public biotechnology and life-sciences companies. He earned his M.D. from the Temple University School of Medicine and his B.S. in Finance from Pennsylvania State University.
An Innovative Business Philosophy
During his impressive twenty-year career, Dr. Lindsay Rosenwald has founded over fifty companies and managed the Aries Funds from 1994 through 2007 with peak assets under his management in 2000 of over $1BB dedicated to healthcare investments. During the years of 2002 through 2006, he also managed the Orion Fund, which was a committed capital fund dedicated to private investments in biotechnology, in particular PIPEs.
The philosophy behind OpusPoint Partners will be to build a successful life science and healthcare network that plays fair and does not take short cuts to reach its goals. Dr. Rosenwald and his associates know that the world we currently live in often provides too many opportunities for business leaders to use less than ethical tactics to try to manipulate outcomes of clinical trials and hence increase quarterly earnings.
OpusPoint Partners is a uniqueenterprise that continually reinforces its commitment to its employees and investors. Their promise is to deal fairly in all aspects of experimental drug trials. In the investigation and manufacture of experimental drugs, they are resolute about these vows.
The Benefits of Making the World a Better Place
The future of OpusPoint Partners remains highly promising with Michael S. Weiss and Dr. Lindsay Rosenwald as its founders. They are utilizing their expertise in the fields of medicine and investments to effect some very real changes in the way diseases are diagnosed. They believe that the treatment of patients can be transformed.
But revolutionizing these age-old medicaland healthcare techniques and procedures is no small task, nor is it for the faint of heart. In order to effect changes on such a grand scale requires commitment; it requires time and money. It also involves a strong resolve to work hard within the ethical boundaries that other drug research companies may have discarded in favor of better profits.
Dr. Rosenwaldunderscoresthe fact that over the past few years, projected goals have already been surpassed. By applying best practices and processes, OpusPoint Partners moves ahead earning superior, risk-adjusted returns and helpingto finance and support more than 20 companies in the past two years alone. This achievement is marked by a continuing commitment to the financial world and the world of drug research.

Credentials and Lifetime Achievements
Dr. LindsayRosenwald is currently a member of the Board of Directors at the Republican Jewish Coalition. He is one of the most broadly-informed and well-connected individuals in the biotechnology finance sector.The future of OpusPoint Partners looks very promising with Dr. Rosenwald as its vanguard.

 
Comments Off

Posted in lindsay rosenwald

 

Lindsay Rosenwald Investing in the Future ofLife Sciences and Healthcare

08 Jun

OpusPoint Partners is an innovative new company with a unique vision for the future of the life science and healthcare industry. That vision includes some cutting edge technologies but also some forward thinking business philosophies.

As with alllofty visionssuchas this, itwill take immense commitment from quality entrepreneurs to accomplish. Michael S. Weiss and Dr. Lindsay Rosenwald created OpusPoint Partners in 2009 with the idea of combining their 40 years of experience and business acumen working toward revolutionizing the fields of healthcare, life sciences and biotechnology investing. Both these men are well equipped to do this job and have already founded a number of biotech companies over the years.

With so much at stake, OpusPoint Partners along with Dr. Lindsay Rosenwald, is working toward making those leaps to advance and even transform the world of life sciences and biotechnology investing. Rosenwald, along with his team at OpusPoint, believe in a future where mankind significantly improves the quality of healthcare, as well as healthcare investing.

Advancements in the Future of Healthcare
Recently, Dr. Lindsay A. Rosenwaldfounded Cougar Biotechnology Inc. This Los Angeles-based company focuses on the field of oncology. Their oncology portfolio includes some very promising experimental drugs, which are proving to be effective in treatingnumerousforms of cancer.

One in particular has caused some excitement and drawn the interests of researchers and investors. It is a new drug that has been proven to work well at treating late-stage prostate cancer. In July of 2009, Dr. Lindsay Rosenwaldwas able to negotiate a deal with Johnson & Johnson for Cougar Biotech Labs at a price of approximately one billion dollars.

Realizing the Objectives
Lindsay Rosenwald and OpusPoint Partners believe they can continue to move forward with projects like these that alter healthcare significantly and produce results for the greater good of mankind. They achieve these goals with integrity, building solid relationships in both the world of investing and biotechnology.

Establishing robust relationships withother industry leaders who share similar values is a hallmark of the business strategy of both Dr. Lindsay Rosenwald and OpusPoint Partners. They believe in reaching goals and objectives through honesty, integrity and hard work. Their success has proven that you can obtain these objectives without the sacrifice ofprinciples and standards. Honest investing with full and open disclosure is more than just good business for OpusPoint Partners. This is the ideology they live by.

Creating New Partnerships for a Better Tomorrow
Dr. Lindsay Rosenwald and OpusPoint Partners currently work with a wide range of businesses and organizations to create a team approach for thesupport of emerging new businesses. They are making great strides toward building a powerful network of like-minded individuals who all possess a genuine commitment to discover and invest in innovative technologies in the fields of life sciences and healthcare.

With pioneers such as these in the areas of research and investment, you can be sure that thefuture of healthcare and life sciences will continue to flourish. These days, the medical field is well-aware of its need for diseases of all types to be diagnosed and treated by more effective methods. At OpusPoint Partners, Dr. Lindsay Rosenwald, his business partners and colleagues, know that the dream can become a reality with hard work and dedication.

The dream of a better tomorrow continues to be the fuel that fires this vision of a much stronger quality of life for us all. And thisunique vision of making a true difference in the world has become a driving force for Dr. Lindsay Rosenwald and OpusPoint Partners. History shows that dreams like this always take time, money and hard work, plus dedication from those involved.

Raising the Bar for Investors
Over the course of this journey, Dr. Lindsay Rosenwald and OpusPoint Partners must oftenprovide advisory services to start-up businesses. At times they also must invest in publicly-traded companies in order to move the vision forward.

One of their key objectives is to raise the bar for all investors. Whether working in the advisory capacity with emerging biotechnical research facilities or actually investing, OpusPoint followsa strong moral compass.With sound business principleslike these, the risks can be significantly minimizedand the returns for investors maximized. This uniqueformula has proven successful beyond anyone’s wildest dreams.

Utilizing Ethical Business Practices
The philosophy behind OpusPoint Partners is to build a positive and effective life science and healthcare network that plays fair and won’t take short cuts to reach its goals. Dr. Rosenwaldknows from experience, that today’s world often provides many opportunities for business leaders to use less than ethical tactics to try and manipulate outcomes of clinical trials with an eye toward greaterquarterly earnings. Does the end justify the means?

At OpusPoint Partners, the answer is a resounding no! This unique enterprise continually reinforces its commitment to its employees and investors to conduct business with higher standards than many of days gone by. In the investigation and manufacture of experimental drugs, they are resolute about this commitment to honest, above-board business dealings.

A Long and Fruitful Career
The future of OpusPoint Partners remains highly promising with Michael S. Weiss and Dr. Lindsay Rosenwald as its founders. They are utilizing their expertise in the fields of medicine and investments to effect some very real changes in the way diseases are diagnosed. They believe that the treatment of patients can be transformed.

Dr. Rosenwald, a well-respected Wall Street biotechnology entrepreneur, has worked for the past 17 years utilizing strong business ethics in the founding and re-capitalization of dozens of private and public biotechnology and life-sciences companies. He earned his M.D. from the Temple University School of Medicine and his B.S. in Finance from Pennsylvania State University.

Throughout an impressive twenty-year career, Dr. Lindsay Rosenwald has established over fifty companies. He also managed the Aries Funds from 1994 through 2007 with peak assets under his management in 2000 of over $1BB dedicated to healthcare investments. From 2002 to 2006, hemanaged the Orion Fund, which was a committed capital fund dedicated to private investments in biotechnology, in particular PIPEs.

Dr. Lindsay Rosenwald is currently a member of the Board of Directors at the Republican Jewish Coalition. He is one of the most broadly-informed and well-connected individuals in the biotechnology finance sector. The future ofOpusPoint Partners indeed looks promising with Dr. Rosenwald at its helm.

 
Comments Off

Posted in lindsay rosenwald

 
« Older Entries